Mother-Daughter Duo, Tori Spelling and Stella McDermott, Partner With Arcutis Biotherapeutics in the Free to Be Me Campaign, Urging People With Inflammatory Skin Conditions to Speak With Their Healthcare Provider About Long-Term Treatments

Core Insights - Arcutis Biotherapeutics launched the "Free to Be Me" awareness campaign to highlight the emotional and physical challenges faced by approximately 36 million Americans with inflammatory skin diseases, including atopic dermatitis and seborrheic dermatitis [1][2][14] - The campaign features actress Tori Spelling and her daughter, who share their personal experiences managing skin conditions with the FDA-approved treatment ZORYVE® (roflumilast) [2][3][4] Company Overview - Arcutis Biotherapeutics is a commercial-stage biopharmaceutical company focused on innovations in immuno-dermatology, with a commitment to addressing the needs of individuals with immune-mediated dermatological diseases [21] - ZORYVE is the number one prescribed branded topical therapy for atopic dermatitis, seborrheic dermatitis, and plaque psoriasis, backed by robust clinical evidence from eight pivotal trials involving approximately 4,200 participants [12][10] Product Information - ZORYVE cream 0.15% is indicated for treating atopic dermatitis in adults and children aged 6 and older, showing a 31% rate of achieving clear or almost clear skin at 4 weeks in clinical trials [6][10] - ZORYVE foam 0.3% is indicated for seborrheic dermatitis in adults and children aged 9 and older, with 77% of users achieving clear or almost clear skin after 8 weeks of treatment [7][10] Clinical Evidence - Clinical trials demonstrated that ZORYVE cream and foam are safe and well-tolerated, with common side effects including headache, nausea, and application site pain [10][18] - The American Academy of Dermatology issued a strong recommendation for ZORYVE cream 0.15% for adult patients with mild to moderate atopic dermatitis, reflecting its clinical significance [13] Campaign Objectives - The "Free to Be Me" campaign aims to empower individuals with inflammatory skin conditions to engage in open conversations with healthcare providers about effective treatment options [14][8] - Tori Spelling's involvement in the campaign seeks to break the stigma surrounding skin conditions and encourage others to take control of their skin health [8][3]